Search Results - "González‐Juanatey, Jose R."

Sacubitril-Valsartan, a New Opportunity for Heart Failure with Recovered Ejection Fraction? by Agra-Bermejo, Rosa, Alvarez Rodríguez, Leyre, González-Juanatey, Jose R

Get more information

Cholinergic activity regulates the secretome of epicardial adipose tissue: Association with atrial fibrillation by Couselo‐Seijas, Marinela, López‐Canoa, Jose N., Agra‐Bermejo, Rosa M., Díaz‐Rodriguez, Esther, Fernandez, Angel L., Martinez‐Cereijo, Jose M., Durán‐Muñoz, Dario, Bravo, Susana B., Velo, Alba, González‐Melchor, Laila, Fernández‐López, Xesus A., Martínez‐Sande, Jose L., García‐Seara, Javier, González‐Juanatey, Jose R., Rodriguez‐Mañero, Moises, Eiras, Sonia

“…Botulinum toxin injection on epicardial fat, which inhibits acetylcholine (ACh) release, reduced the presence of atrial fibrillation (AF) in patients after…”
Get full text

A New Biomarker Tool for Risk Stratification in " de novo " Acute Heart Failure (OROME) by Agra-Bermejo, Rosa M, Cacho-Antonio, Carla, Gonzalez-Babarro, Eva, Rozados-Luis, Adriana, Couselo-Seijas, Marinela, Gómez-Otero, Inés, Varela-Román, Alfonso, López-Canoa, José N, Gómez-Rodríguez, Isabel, Pata, María, Eiras, Sonia, González-Juanatey, Jose R

“…Inflammation is one of the mechanisms involved in heart failure (HF) pathophysiology. Thus, the acute phase reactant protein, orosomucoid, was associated with…”
Get full text

Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: real world evidence by Agra-Bermejo, Rosa, Cordero, Alberto, Veloso, Pedro Rigueiro, Álvarez, Diego Iglesias, Álvarez, Belen Álvarez, Díaz, Brais, Rodríguez, Leyre Alvarez, Abou-Jokh, Charigan, Álvarez, Belén Cid, González-Juanatey, Jose R., Acuña, Jose M García

“…The benefit of complete revascularization in elderly patients with non-ST elevation myocardial infarction (NSTEMI), and multivessel disease remains debated…”
Get full text

Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes? by Abu-Assi, Emad, MD, Ferreira-González, Ignacio, MD, PhD, Ribera, Aida, BSc, PhD, Marsal, Josep R., BSc, Cascant, Purificación, RN, Heras, Magda, PhD, MD, Bueno, Héctor, PhD, MD, Sánchez, Pedro L., MD, PhD, Arós, Fernando, MD, PhD, Marrugat, Jaume, MD, PhD, García-Dorado, David, MD, PhD, Peña-Gil, Carlos, MD, PhD, González-Juanatey, Jose R., MD, PhD, Permanyer-Miralda, Gaietà, MD, PhD

“…Background Although the GRACE risk scores (RS) are the preferred scoring system for risk stratification in acute coronary syndromes (ACS), little is known…”
Get full text

Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes by Rodríguez-Mañero, Moisés, Cordero, Alberto, Kreidieh, Omar, García-Acuña, Jose Mª., Seijas, Jose, Agra-bermejo, Rosa María, Abou-Jokh, Charigan, Álvarez-Rodríguez, Leyre, Álvarez-Iglesias, Diego, López-Palop, Ramón, Cid, Belen, Carrillo, Pilar, González-Juanatey, Jose R.

“…HF remains a frequent complication following MI and adversely affects prognosis. The objective of this study was to identify predictors of HF following MI and…”
Get full text

Periodontitis and cardiovascular diseases: Consensus report by Sanz, Mariano, Marco del Castillo, Alvaro, Jepsen, Søren, Gonzalez‐Juanatey, Jose R., D’Aiuto, Francesco, Bouchard, Philippe, Chapple, Iain, Dietrich, Thomas, Gotsman, Israel, Graziani, Filippo, Herrera, David, Loos, Bruno, Madianos, Phoebus, Michel, Jean‐Baptiste, Perel, Pablo, Pieske, Burkert, Shapira, Lior, Shechter, Michael, Tonetti, Maurizio, Vlachopoulos, Charalambos, Wimmer, Gernot

“…Background In Europe cardiovascular disease (CVD) is responsible for 3.9 million deaths (45% of deaths), being ischaemic heart disease, stroke, hypertension…”
Get full text

Managing NSTEMI in older patients by Cordero, Alberto, Rodríguez-Mañero, Moisés, Bertomeu-González, Vicente, González-Juanatey, Jose R

Get full text

Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer by Couselo‐Seijas, Marinela, Almengló, Cristina, Agra‐Bermejo, Rosa, Fernandez, Ángel, Alvarez, Ezequiel, González‐Juanatey, Jose, Eiras, Sonia

“…Aims Obesity, diabetes and cardiovascular disease are associated with COVID‐19 risk and severity. Because epicardial adipose tissue (EAT) expresses ACE2, we…”
Get full text

Estimation of the major cardiovascular events prevention with Inclisiran by Cordero, Alberto, Santos-Gallego, Carlos G., Fácila, Lorenzo, Rodríguez-Mañero, Moisés, Bertomeu-González, Vicente, Castellano, Jose M, Seijas-Amigo, José, Núñez, Julio, Zuazola, Pilar, González-Juanatey, Jose R., Badimon, Juan J.

“…The ORION 10–11 trials have reported the efficacy of Inclisiran on low-density lipoprotein cholesterol (LDLc) reduction, and also suggested prevention of major…”
Get full text

Prevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index by Mostaza, Jose M., MD, PhD, González-Juanatey, Jose R., MD, PhD, Castillo, Jose, MD, PhD, Lahoz, Carlos, MD, PhD, Fernández-Villaverde, Jose M., MD, PhD, Maestro-Saavedra, Francisco J., MD

“…Objective Subjects with symptomatic peripheral artery disease (PAD) have an elevated prevalence of carotid stenosis and of silent myocardial ischaemia. As…”
Get full text

Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study by Roselló-Lletí, Esther, Calabuig, Jose R, Morillas, Pedro, Cortés, Raquel, Martínez-Dolz, Luis, Almenar, Luis, González-Juanatey, Jose R, Lauwers, Catheline, Salvador, Antonio, Portolés, Manuel, Bertomeu, Vicente, Rivera, Miguel

“…The variability of NT-proBNP levels has been studied in heart failure, yet no data exist on these changes over time in hypertensive patients. Furthermore,…”
Get full text

Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI) by García del Blanco, Bruno, Otaegui, Imanol, Rodríguez-Palomares, José F., Bayés-Genis, Antoni, Fernández-Nofrerías, Eduard, Vilalta del Olmo, Victoria, Carrillo, Xavier, Ibáñez, Borja, Worner, Fernando, Casanova, Juan, Pueo, Eva, González-Juanatey, Jose R., López-Pais, Javier, Bardají, Alfredo, Bonet, Gil, Fuertes, Mónica, Rodríguez-Sinovas, Antonio, Ruiz-Meana, Marisol, Inserte, Javier, Barba, Ignasi, Gómez-Talavera, Sandra, Martí, Gerard, Serra, Bernat, Bellera, Neus, Ojeda-Ramos, Manuel, Cuellar, Hug, Valente, Filipa, Carmona, Maria Ángeles, Miró-Casas, Elisabet, Marsal, Josep R., Sambola, Antonia, Lidón, Rosa M., Bañeras, Jordi, Elízaga, Jaime, Padilla, Ferran, Barrabés, José A., Hausenloy, Derek J., Ferreira-González, Ignacio, García-Dorado, David

“…Remote ischemic conditioning (RIC) and the GLP-1 analog exenatide activate different cardioprotective pathways and may have additive effects on infarct size…”
Get full text

Updates on epicardial adipose tissue mechanisms on atrial fibrillation by Couselo‐Seijas, Marinela, Rodríguez‐Mañero, Moisés, González‐Juanatey, José R., Eiras, Sonia

“…Summary Obesity is a well‐known risk factor for atrial fibrillation (AF). Local epi‐myocardial or intra‐myocardial adiposity caused by aging, obesity, or…”
Get full text

Differential Effect of β‐Blockers for Heart Rate Control in Coronary Artery Disease by Cordero, Alberto, Bertomeu‐González, Vicente, Mazón, Pilar, Moreno‐Arribas, José, Fácila, Lorenzo, Bueno, Héctor, González‐Juanatey, Jose R., Bertomeu‐Martínez, Vicente

“…Background: Resting heart rate is an independent risk factor for cardiovascular disease and is mainly controlled by β‐blockers (BBs). BBs are part of the…”
Get full text

Additive value of the CRUSADE score to the GRACE score for mortality risk prediction in patients with acute coronary syndromes by Cordero, Alberto, Rodriguez-Manero, Moisés, García-Acuña, Jose M., López-Palop, Ramón, Cid, Belen, Carrillo, Pilar, Agra-Bermejo, Rosa, González-Salvado, Violeta, Iglesias-Alvarez, Diego, Bertomeu-Martínez, Vicente, González-Juanatey, Jose R.

“…Acute coronary syndrome (ACS) treatments increase bleeding complications that also impair prognosis. Bleeding risk scores reclassification of actual mortality…”
Get full text

Long-term prognosis of women with Brugada syndrome and electrophysiological study by Rodríguez-Mañero, Moisés, Jordá, Paloma, Hernandez, Jaime, Muñoz, Carmen, Grima, Esther Zorio, García-Fernández, Amaya, Cañadas-Godoy, María Victoria, Jiménez-Ramos, Victor, Oloriz, Teresa, Basterra, Nuria, Calvo, David, Pérez-Álvarez, Luisa, Arias, Miguel A., Expósito, Victor, Alemán, Ailema, Díaz-Infante, Ernesto, Guerra-Ramos, Jose María, Fernández-Armenta, Juan, Arce-Leon, Álvaro, Sanchez-Gómez, Juan M., Sousa, Pedro, García-Bolao, Ignacio, Baluja, Aurora, Campuzano, Oscar, Sarquella-Brugada, Georgia, Martinez-Sande, Jose Luis, González-Juanatey, Jose R., Gimeno, Juan Ramón, Brugada, Josep, Arbelo, Elena

“…A male predominance in Brugada syndrome (BrS) has been widely reported, but scarce information on female patients with BrS is available. The purpose of this…”
Get full text

Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events by Cordero, Alberto, Ferreiro, José L., Bertomeu-González, Vicente, Rodríguez-Mañero, Moisés, Fácila, Lorenzo, Escribano, David, Sanchez-Recalde, Angel, Zuazola, Pilar, Ruiz-Nodar, Juan M., González-Juanatey, Jose R.

“…Clinical trials have assessed the effect of direct oral antagonists (DOACs) in patients with atrial fibrillation (AF) after percutaneous coronary interventions…”
Get full text

Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome by Cordero, Alberto, Rodriguez-Mañero, Moisés, García-Acuña, Jose M., Bertomeu-González, Vicente, Agra-Bermejo, Rosa, Cid, Belen, Alvarez, Belen, Bertomeu-Martínez, Vicente, González-Juanatey, Jose R.

“…Stroke is one the most feared cardiovascular disease due to its high risk of disability and its incidence after an acute coronary syndrome (ACS) is not…”
Get full text

Cardiorenal benefits of finerenone: protecting kidney and heart by González-Juanatey, José R., Górriz, Jose Luis, Ortiz, Alberto, Valle, Alfonso, Soler, Maria Jose, Facila, Lorenzo

“…Persons with diabetes and chronic kidney disease (CKD) have a high residual risk of developing cardiovascular (CV) complications despite treatment with…”
Get full text